Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEGI for acute cerebral infarction
ChiCTR1800017937Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Oct 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in brain infarction and ischemic stroke comparing CEGI group with Placebo group (2 arms). Primary endpoint: modified Rankin Scale on day 90. Started Oct 2013; status: completed.
02
Drugs
cerebroside + carnosine
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR1800017937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017937.